Skip to main content

Table 1 Numbers of patients fulfilling the inclusion criteria with required information

From: Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

Inclusion criteria N
Adults with ALL in CR1 or CR2 allografted from MSD or UD 10/10 or UD 9/10 from January 2000 to December 2017 10,418
Myeloablative conditioning 8400
Available information
 Immunophenotype B or T and Philadelphia status 5540
 MRD status before transplantation reported 2780